Persistent pulmonary hypertension of the newborn; Nitric oxide; Sildenafil
Abstract :
[en] Persistent pulmonary hypertension of the newborn is a severe disease leading to persistent and refractory hypoxemia with bad outcomes. The introduction of inhaled nitric oxide therapy significantly improved short and long term prognosis of those infants. More recently, sildenafil also appeared promising, but regimen and indications still need to be delineated.
Konduri GG. - New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol, 2004, 31, 591-611.
Finer NN, Barrington KJ. - Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev, 2006, CD000399.
Steinhorn RH, Farrow KN. - Pulmonary hypertension in the neonate. Neoreviews, 2007, 8, e14-e21.
Fondation Nobel. - Lauréats 1998. http://nobelprize.org/ nobel_prizes/medicine/laureates/1998/. Consulté le 13 mars 2007.
Weinberger B, Laskin DL, Heck DE, et al. - The toxicology of inhaled nitric oxide. Toxicol Sci, 2001, 59, 5-16.
Barrington KJ, Finer NN. - Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev, 2006, CD000509.
The Franco-Belgium Collaborative NO Trial Group. - Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet, 1999, 354, 1066-1071.
Hascoet JM, Fresson J, Claris O, et al. - The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr, 2005, 146, 318-323.
Kinsella JP, Cutter GR, Walsh WF, et al. - Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med, 2006, 355, 354-364.
Ballard RA, Truog WE, Cnaan A, et al. - Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med, 2006, 355, 343-353.
Desandes R, Desandes E, Droulle P, et al. - Inhaled nitric oxide improves oxygenation in very premature infants with low pulmonary blood flow. Acta Paediatr, 2004, 93, 66-69.
Jacobs P, Finer NN, Fassbender K, et al. - Cost-effectiveness of inhaled nitric oxide in near-term and term infants with respiratory failure: eighteen- to 24-month follow-up for Canadian patients. Crit Care Med, 2002, 30, 2330-2334.
INAMI. - Banque de données des spécialités pharmaceutiques. http://www.inami.fgov.be/inami_prd/ssp/cns2/pages/ SpecialityCns.asp. Consulté le 12 mars 2007.
Lewin S. - Viagra neonatal experimentation - the Pandora's box! Indian Pediatr, 2002, 39, 894-895.
Patole S, Travadi J. - Sildenafil for «blue babies»: Ethics, conscience, and science have to be balanced against limited resources. BMJ, 2002, 325, 1174.
Shekerdemian LS, Ravn HB, Penny DJ. - Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med, 2002, 165, 1098-1102.
Martell M, Blasina F, Silvera F, et al. - Intratracheal sildenafil in the newborn with pulmonary hypertension. Pediatrics, 2007, 119, 215-216.
Baquero H, Soliz A, Neira F, et al. - Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics, 2006, 117, 1077-1083.
